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Abstract L-Carotene has often been discussed as a means to
reduce the risk of skin photodamage. We studied the antiox-
idative potential of L-carotene in human skin fibroblasts exposed
to ultraviolet A light. Surprisingly, we found a pro-oxidative
effect of L-carotene. Using the induction of haem oxygenase-1 as
a marker for oxidative stress, we found a strong enhancement of
gene expression by L-carotene in ultraviolet A-irradiated cells.
This effect was clearly suppressed by concomitant addition of
vitamin E but only moderately by vitamin C. The results show
that L-carotene has pro-oxidative properties in human skin
fibroblasts exposed to ultraviolet-A light.
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1. Introduction
Carotenoids have been extensively studied as chemopreven-
tive agents that may reduce the risk of skin photodamage [1].
L-Carotene supplementation was found to be a successful
therapy against certain photosensitivity diseases, e.g. erythro-
poietic protoporphyria [2]. Regarding normal skin, several
reports exist showing short-term photoprotective e¡ects of
L-carotene supplementation, e.g. decreased formation of
erythema [3,4], whereas others show no bene¢cial e¡ects [5^
7]. The in£uence of L-carotene on photocarcinogenesis was
reported to be preventive [8], but in contrast to these ¢ndings,
some authors described ine¡ectiveness [9] or even exacerba-
tion of tumour development by L-carotene [10]. As exposure
to natural or arti¢cial sunlight is steadily increasing as a result
of changing leisure habits and environmental conditions, the
intake of dietary L-carotene supplements to support the e¡ect
of sunscreens has been recommended [3].
Few data exist about how L-carotene acts in vitro in skin
exposed to ultraviolet (UV) light. It has been supposed that L-
carotene might act as an antioxidant [3] defeating UVA-gen-
erated cutaneous oxidative stress [11]. Although knowledge
about the modulation of UV e¡ects in skin cells by anti-
oxidants is limited, cellular antioxidant defence mechanisms
seem to be crucial to the prevention of oxidative UV skin
damage [12]. An accepted marker for the onset of oxidative
damage to skin is the expression of haem oxygenase-1 (HO-1)
[13], which appears to be redox-regulated [14]. Haem oxygen-
ase is a microsomal enzyme which catalyses the rate-limiting
step in haem catabolism leading to the formation of carbon
monoxide, ferrous iron and biliverdin, which is subsequently
converted to bilirubin. The HO-1 isoenzyme is ubiquitously
expressed and is inducible by the substrate haem itself, as well
as a variety of agents leading to the formation of reactive
oxygen species, e.g. UVA light [14]. Induction of HO-1 by
irradiation with UVA light seems to be involved in an adap-
tive cellular defense mechanism against oxidative damage
through increasing cellular levels of antioxidant biliverdin
and bilirubin, as well as inducing ferritin synthesis [15]. The
e¡ector species for UVA-mediated HO-1 up-regulation seems
to be photochemically generated singlet oxygen [16], which
causes damaging e¡ects on biomolecules [17]. L-Carotene is
accepted to be an e⁄cient singlet oxygen quencher [18]. How-
ever, the extent to which this property plays a role in protect-
ing against skin photodamage is unknown.
In the present study we investigated the antioxidant poten-
tial of L-carotene in human skin ¢broblasts exposed to UVA
light in vitro. Surprisingly, we found, in contrast to the ex-
pected antioxidative e¡ect, that L-carotene had a pro-oxida-
tive e¡ect. Using the induction of HO-1 as a marker for ox-
idative stress, we found a strong enhancement of HO-1
mRNA and protein induction by L-carotene in UVA-irradi-
ated cells. This e¡ect was clearly suppressed by concomitant
addition of vitamin E, but only moderately by vitamin C.
2. Materials and methods
2.1. Chemicals
All chemicals were purchased from Sigma (St. Louis, MO, USA)
unless otherwise indicated. Tissue culture media, serum and supple-
ments were obtained from Biochrom (Berlin, Germany) unless other-
wise indicated. Methyl-L-cyclodextrin (MLCD) was purchased from
RBI (Natick, MA, USA), RRR-K-tocopherol from Ho¡mann-La
Roche (Basel, Switzerland) and L-ascorbic acid from Merck (Darm-
stadt, Germany).
2.2. Cell culture
HFP-1 normal human skin ¢broblasts were derived from biopsy
material of the lower abdomen and cultured as described previously
[19]. For all experiments con£uent, contact-inhibited cell populations
were used at passages 9^18, corresponding to cumulative population
doubling levels (CPDLs) 12^23.
2.3. Preparation of supplement solutions
Lipophilic supplements were prepared as water-soluble aqueous
complexes of MLCD in order to avoid organic solvents. All-trans L-
carotene was prepared as a 1 mM MLCD stock solution similar to the
method described previously [19]. RRR-K-tocopherol was prepared as
a 57 mM MLCD stock solution by dissolving 1 g M LCD in 2 ml
bidistilled water, adding 250 mg RRR-K-tocopherol and mixing for
24 h under N2 atmosphere. L-Ascorbic acid was prepared as a 0.1 M
stock in phosphate-bu¡ered saline (PBS) [20]. All supplement solu-
tions were prepared with a minimum of light exposure, ¢ltered sterile
and stored at 380‡C, except for the L-ascorbic acid stock solution,
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which was prepared fresh. All-trans L-carotene and RRR-K-tocopher-
ol stock solutions were tested for concentrations by spectrophotomet-
ric means. The purity of the RRR-K-tocopherol stock solution was
determined by high-performance liquid chromatography (HPLC) ac-
cording to a modi¢cation of the previously described method [21]. A
250U4 mm Grom-Sil 100 Cyano-2 PR column (Grom, Herrenberg,
Germany) was used with a £ow rate of 1.5 ml/min. The eluent was n-
hexane:2-propanol (98.5:1.5). The purity of the all-trans L-carotene
stock solution was determined by HPLC using a 250U4.6 mm
YMC30 column (YMC, Kyoto, Japan). Eluent A was methanol:
tert-butylmethylether:water (81:15:4), eluent B was methanol:tert-bu-
tylmethylether:water (6:90:4). A gradient was performed from 100%
A to 0% A in 90 min with a £ow rate of 1 ml/min.
2.4. Treatment with supplements
Cells were seeded at a density of 3U105 or 1U106 cells per 21 cm2
or 58 cm2 tissue culture dish, respectively. Twenty-four hours after
inoculation the medium was renewed and the cells were grown to
100% con£uence for 1 week. On day 7 (i.e. 7 days before UV irradi-
ation) media were replaced by fresh medium without phenol red as
described previously [19], and cells were preincubated for 7 days with
L-carotene (0.5 or 5.0 WM), or vehicle alone.
If required, cells were concomitantly preincubated with K-tocopher-
ol (10 or 25 WM) 4 days before UV irradiation, and/or with ascorbic
acid (50 or 100 WM) 90 min before UV irradiation. All cells received
the same amounts of vehicle (¢nal concentration below 0.2% MLCD).
On day 14 after inoculation cells were UV-irradiated or sham-irradi-
ated.
2.5. UV irradiation
Cells were irradiated with 20 J/cm2 UVA light as described previ-
ously [19]. In brief, cells were washed (twice) and 21 cm2 dishes were
covered with 2 ml and 58 cm2 dishes with 5 ml Hanks’ balanced salt
solution (HBSS). Irradiation was carried out on a heating platform
at 37‡C in a UV irradiation chamber (Dr Gro«bel UV Elektronik,
Ettlingen, Germany). The UVA light source (TLD15W/05 lamps,
Philips, Hamburg, Germany) emitted radiation in the range of 300^
460 nm with a maximum at 365 nm and with a £uence of 2.1 W UVA
and 6 0.01 W UVB light, according to the manufacturer. The UV
dose was measured with a UV-MAT dosimeter and cosine-corrected
sensors RM-11UVA and RM-11UVB. After irradiation, cells were fed
with the saved conditioned medium. Sham-irradiated cells were
treated in the same manner except that they were not irradiated.
2.6. Western blot analysis
Immediately on irration or 48 h p.i. cells were rinsed twice and
harvested with ice-cold PBS. Cell pellets were lysed in 60 mM Tris,
pH 6.8, containing 2% SDS, 5% 2-mercaptoethanol, 10% glycerol,
benzonase (1:5000) and protease inhibitors Pefabloc SC (2 mM; Bio-
mol, Hamburg, Germany), leupeptin (1 WM) and pepstatin A (1 WM;
Calbiochem, CA, USA). The protein content was determined in an
aliquot after dilution (1:100) with the Bio-Rad protein assay (Bio-
Rad, Munich, Germany) and bovine serum albumin (BSA) for cali-
bration. 20 Wg of total cell lysate proteins were electrophoresed on a
12% SDS-polyacrylamide gel and then blotted onto PVDF mem-
branes (Boehringer, Mannheim, Germany). The blots were blocked
in Tris-bu¡ered saline (TBS) containing 0.05% Tween 20 (TTBS)
and 3% BSA (w/v) at room temperature for 30 min. Blots were in-
cubated with rabbit polyclonal anti-HO-1 antibody (dilution 1:20 000)
for 1 h at room temperature in TTBS containing 1% BSA (w/v). After
two washes in TTBS, blots were incubated with alkaline phosphatase-
conjugated goat anti-rabbit IgG (dilution 1:3000) for 30 min at room
temperature. After three washes in TTBS and two washes in TBS the
colour was developed using NBT/BCIP as the substrate.
2.7. HO-1 cDNA probe
A 365 bp cDNA probe for HO-1 was generated by polymerase
chain reaction (PCR). Oligonucleotide primers for HO-1 (forward,
5P-TTC TTC ACC TTC CCC AAC-3P ; reverse, 5P-GCA TAA AGC
CCT ACA GCA AC-3P) were designed based on the complete coding
sequence of the human HO-1 mRNA (accession number X06985).
Total RNA was extracted from human microvascular endothelial
cells (HMEC-1) [22] and used for poly(A) selection to isolate mRNA
according to the manufacturer’s instruction for the Oligotex mRNA-
kit (Qiagen, Hilden, Germany). The mRNA was used to synthesise
cDNA by means of the SuperScript kit (Gibco-BRL, Eggenstein,
Germany). For the PCR ampli¢cation a 50 Wl reaction contained
2 Wl ss cDNA solution from the reverse transcription step, 3 units
of Vent DNA polymerase (Biolabs, Schwalbach, Germany), 1 mM of
each of the four deoxynucleoside triphosphates, and 50 pmol/l of each
HO-1 primer. After denaturing at 94.5‡C for 5 min the thermocycling
was carried out at 94.5‡C for 1 min, 60‡C for 2 min and 72‡C for
3 min. Forty-¢ve cycles were employed, followed by a ¢nal extension
step at 72‡C for 10 min. The speci¢c ampli¢ed DNA fragment was
cloned into the pZeroTM-1 vector (Invitrogen, Groningen, The
Netherlands) and sequenced by 4base lab GmbH (Reutlingen, Ger-
many). The nucleotide sequence of the cloned PCR product was
found to be 100% identical to human HO-1 mRNA.
2.8. RNA extraction and Northern blot analysis
Total RNA was isolated according to the manufacturer’s instruc-
tions for the RNeasy Mini Kit (Qiagen, Hilden, Germany) and ana-
lysed by Northern blot hybridisation with speci¢c cDNA probes for
HO-1 and L-actin as described elsewhere [23,24]. 10 Wg of total RNA
was denatured with 10% formaldehyde and 65% formamide, stained
with 1.5 ng/lane ethidium bromide and separated through 1% agarose
formaldehyde gels. Transfer of RNA to positively charged nylon
membranes (Boehringer, Mannheim, Germany) was carried out by
capillary blotting with 20USSC for 15^17 h. DNA probes were la-
beled with [32P]dCTP (Freiburg, Germany) by primer extension using
random hexanucleotides (High Prime Labeling System, Boehringer,
Mannheim, Germany). Filters were preincubated for 2 h at 68‡C in
a solution containing 0.25 M Na2HPO4, 1% BSA, 1 mM EDTA, and
7% SDS. The hybridisation was carried out for 16^20 h at 68‡C in the
same solution containing 2.5^4 ng/ml of labeled cDNA. After hybrid-
isation ¢lters were washed at the ¢nal stringency of 20 mM phosphate
bu¡er, 1 mM EDTA, and 1% SDS at 68‡C. Filters were exposed at
380‡C for up to 24 h depending on the level of expression. mRNA
transcripts were quanti¢ed by densitometric scanning of the blots with
the Herolab E.A.S.Y enhanced analysis system (Herolab, Wiesloch,
Germany). To correct for di¡erences in gel loading, integrated optical
densities were normalised to human L-actin, obtained on the same
blot.
Fig. 1. Enhanced UVA induction of HO-1 protein by L-carotene.
HFP-1 ¢broblasts were preincubated with (+) or without (3) L-car-
otene (BC) as indicated and then irradiated with 20 J/cm2 UVA
light (+) or sham-irradiated (3). Cells were harvested at di¡erent
time intervals p.i. and analysed for HO-1 protein levels by Western
blotting. Blots shown are representative of three independent experi-
ments.
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3. Results
3.1. Enhanced UVA induction of HO-1 by L-carotene
HFP-1 normal human skin ¢broblasts were preincubated
with 0.5 or 5.0 WM L-carotene and irradiated with 20 J/cm2
UVA light or sham-irradiated. The kinetics of HO-1 induction
was analysed at the protein (Fig. 1) and mRNA (Fig. 2) levels.
L-Carotene preincubation showed no in£uence on basal levels
of HO-1 protein and mRNA in sham-irradiated cells. UVA
irradiation clearly induced HO-1 expression at both levels.
This is in keeping with previous reports [15,25]. Preincubation
of HFP-1 with L-carotene strongly enhanced the UVA induc-
tion of HO-1 with e¡ects dependent on both dose and time.
At the protein level (Fig. 1), UVA-irradiated cells showed a
maximum HO-1 induction at 12 h p.i. and declined to basal
levels at 24 h p.i. In contrast, cells preincubated with L-car-
otene before irradiation showed a maximum HO-1 protein
induction 18 h p.i. and the up-regulation was prolonged until
24 h p.i. The L-carotene enhanced UVA induction of HO-1
was con¢rmed at the mRNA level (Fig. 2A^C). Preincubation
with 0.5 WM or 5.0 WM L-carotene before UVA irradiation
resulted in a 1.4- or 2.9-fold HO-1 mRNA up-regulation,
respectively, within 2 h p.i., compared to cells not treated
with L-carotene (Fig. 2B). These levels remained approxi-
mately constant until at least 6 h p.i. (data not shown).
3.2. Modulation of L-carotene-enhanced HO-1 induction by
vitamins E and C
Ascorbic acid and K-tocopherol were concomitantly added
to L-carotene- or vehicle-preincubated ¢broblasts. The cells
were then irradiated with 20 J/cm2 UVA light or sham-irra-
Fig. 2. Enhanced UVA induction of HO-1 mRNA by L-carotene. Cells were treated as described in Fig. 1. Total RNA was isolated 1 h p.i.
(A), 2 h p.i. (B) or 4 h p.i. (C) and analysed for HO-1 mRNA levels by Northern blotting. Densitometric values obtained for the HO-1
mRNA transcripts were normalised to values for L-actin which were obtained from the same blot. Controls were set 100%. Data presented are
the result of one experiment.
Fig. 3. E¡ect of ascorbic acid on L-carotene enhanced HO-1 protein
induction. HFP-1 ¢broblasts were preincubated with (+) or without
(3) L-carotene (BC) and ascorbic acid (VC) as indicated. Then cells
were irradiated with 20 J/cm2 UVA light or sham-irradiated (con-
trol). Cells were harvested 12 h p.i. and analysed for HO-1 protein
levels by Western blotting. Blots shown are representative of three
independent experiments.
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diated. HO-1 induction was analysed 12 h p.i. at the protein
level. We found in sham-irradiated cells (Fig. 3) that 50 WM or
100 WM ascorbic acid had no in£uence on HO-1 protein basal
levels with or without L-carotene preincubation. In UVA-ir-
radiated cells ascorbic acid showed a moderate suppressing
e¡ect on HO-1 protein expression.
Incubation with 10 WM or 25 WM K-tocopherol (Fig. 4)
resulted in a moderate decrease of HO-1 protein basal levels
in sham-irradiated cells, regardless of L-carotene preincuba-
tion. In contrast to the ascorbic acid treatment, in UVA-irra-
diated cells K-tocopherol clearly suppressed HO-1 protein ex-
pression in a dose-dependent manner.
Cells treated with a combination of 25 WM K-tocopherol
and 100 WM ascorbic acid (Fig. 4) showed a moderate de-
crease of HO-1 protein basal levels with or without L-carotene
preincubation. After UVA irradiation the HO-1 induction was
clearly suppressed in cells treated with a combination of K-
tocopherol and ascorbic acid when preincubated with 0 or 0.5
WM L-carotene whereas preincubation with 5.0 WM L-carotene
resulted in a diminished suppression of HO-1.
4. Discussion
In the present study we investigated the e¡ect of L-carotene
on induction of the stress protein HO-1 in human skin ¢bro-
blasts exposed to UVA light. From the well-known antioxi-
dative action of L-carotene [26,27] we expected a dose-depend-
ent suppression of the UV-induced stress response but,
surprisingly, we found a strong enhancement of HO-1 expres-
sion by L-carotene on mRNA and protein levels. This indi-
cates a pro-oxidative potential of L-carotene in human skin
¢broblasts exposed to UVA light. In order to further address
the question whether the generation of reactive oxygen species
by L-carotene that might result in lipid peroxidation was in-
deed responsible for the increase of HO-1 stress response, we
concomitantly added antioxidant vitamins C and E. In our
experiments vitamin C had no clear modulating e¡ect on the
L-carotene enhancement of HO-1 induction. In contrast, lip-
ophilic vitamin E suppressed HO-1 induction dose-depend-
ently to basal levels in L-carotene- and vehicle-preincubated
cells.
These observations provide evidence that L-carotene does
act as a pro-oxidant. To our knowledge this is the ¢rst report
of a pro-oxidative action of L-carotene in skin cells exposed to
UV light. Previous indications of pro-oxidative properties of
L-carotene were described in vitro and in vivo under rather
non-physiological conditions regarding oxygen tension, L-car-
otene concentration and interactions with other antioxidants
[28]. In our system we simulated cutaneous UVA exposure
using physiologically relevant doses of micronutrients and
UVA radiation. For preincubation of cells with L-carotene
0.5 WM or 5.0 WM solutions were used, corresponding to
human plasma levels without or with moderate oral L-caro-
tene supplementation, respectively [29]. Irradiation was
achieved with a full spectrum of suberythemal 20 J/cm2
UVA light [30].
It might be questioned whether the observed pro-oxidative
e¡ect of L-carotene could be attributed to any oxidation or
degradation products which could be inherent in a commer-
cial L-carotene product. This is rather unlikely because via
analysis of the used L-carotene and MLCD-stock solution
by HPLC no oxidation or degradation products of L-carotene
were detected. The MLCD-stock solution of L-carotene con-
sisted of 96% all-trans L-carotene and the remaining 4% were
identi¢ed as 15-cis, 13-cis and 9-cis L-carotene. Additionally,
we carried out a liquid chromatography mass spectrometric
(LC/MS) analysis (data not shown) which con¢rmed the re-
sults of the HPLC analysis. From the analytical methods ap-
plied, we conclude that the L-carotene used is of su⁄cient
purity and the described pro-oxidative e¡ect can be attributed
to L-carotene, and mainly to all-trans L-carotene.
We assume that the pro-oxidative e¡ect of L-carotene oc-
curs mainly in the membrane region of the cell which might be
concluded from the fact that carotenoids are detected predom-
inantly in cell membranes [31]. This is supported by our ¢nd-
ings that vitamin E, which is mainly located in the membrane,
in£uences the action of L-carotene.
Concerning the discussed bene¢cial e¡ect of L-carotene in
skin exposed to sunlight, it has been reported that L-carotene
acts only in part as an optical ¢lter [32]. L-Carotene is sup-
posed to act mainly as quencher of activated oxygen species in
the skin and this property was attributed to its photoprotec-
tive e¡ects in vitro [20] and in vivo [3]. In contrast, instead of
a suppression of the oxidative stress-derived HO-1 cascade, we
identi¢ed an increase in cutaneous UVA stress response.
Why L-carotene has a pro-oxidative e¡ect under UVA light
exposure may only be hypothesised to date. UVA irradiation
results in lipid peroxidation in human skin ¢broblasts [19] and
subsequent activation of the HO-1 cascade [33]. This is con-
¢rmed by our ¢nding that vitamin E, a chain-breaking anti-
oxidant [34], reduces HO-1 response. It can be assumed that
after UVA exposure either L-carotene itself or any degrada-
tion products (apo-carotenals) enhance lipid peroxidation
which again is abolished via the antioxidative action of vita-
min E. This might explain why in our experiments vitamin E
had a strong suppressing e¡ect on HO-1 induction in contrast
to vitamin C. L-Carotene itself seems unlikely to induce lipid
peroxidation in the skin [35].
Interestingly, we found the same pro-oxidative e¡ect for the
non-provitamin A carotenoid lycopene (unpublished data).
Consequently, the oxidising properties seem to be inherent
in the carotenoid molecule itself or in any photodegradation
products, regardless of provitamin A activity. Further inves-
Fig. 4. E¡ect of K-tocopherol on L-carotene-enhanced HO-1 protein
induction. HFP-1 ¢broblasts were preincubated with (+) or without
(3) L-carotene (BC), K-tocopherol (VE) and ascorbic acid (VC) as
indicated. Then cells were irradiated with 20 J/cm2 UVA light or
sham-irradiated (control). Cells were harvested 12 h p.i. and ana-
lysed for HO-1 protein levels by Western blotting. Blots shown are
representative of three independent experiments.
FEBS 22779 15-10-99
U.C. Obermu«ller-Jevic et al./FEBS Letters 460 (1999) 212^216 215
tigations are necessary to ¢nd out precisely what happens to
the L-carotene molecule under UVA exposure and to identify
the e¡ector species for the HO-1 induction in this respect.
A further possible sun-protective mechanism of action of L-
carotene might result from partial metabolisation into the
vitamin A metabolite retinoic acid. It has been reported that
retinoic acid prevents and repairs skin photodamage [36] and
thus elicits anti-photoaging and anti-photocarcinogenic ef-
fects. As a result, vitamin A has recently been called ‘anti-
sunshine vitamin A’ [37]. However, to our knowledge no data
on retinoic acid formation from L-carotene in skin ¢broblasts
are yet available.
As regards our ¢ndings, L-carotene might combine bene¢-
cial and detrimental e¡ects under light exposure to skin that
could depend on the wavelength and on the indicator of pho-
todamage investigated [38]. Such a paradox of a molecule
causing both toxic and protective cellular e¡ects has also
been observed in other e¡ectors, e.g. nitric oxide [39].
An accumulation of L-carotene in the human skin following
oral supplementation or forti¢cation of foods might lead to
an imbalance in the cutaneous antioxidative system and there-
fore cause oxidative damage in UVA light-exposed skin. Our
results emphasise that skin photoprotection seems to be com-
plex and cannot be managed by the administration of L-car-
otene alone. We strongly recommend that dietary supplements
of L-carotene should be taken only in combination with vita-
min E, if at all.
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